Overview
Etoricoxib vs Aceclofenac in the Treatment of Patients With Rheumatoid Arthritis
Status:
Completed
Completed
Trial end date:
2007-07-31
2007-07-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
Comparison of lower dosage etoricoxib (60 mg daily) with aceclofenac (100 mg bid) for their efficacy and safety in the treatment of rheumatoid arthritis (RA).Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Chung Shan Medical UniversityTreatments:
Aceclofenac
Diclofenac
Etoricoxib
Criteria
Inclusion Criteria:- Diagnosis as Rheumatoid Arthritis
Exclusion Criteria:
- 1. Pregnant or breast-feeding women. 2. Chemotherapy or radiation therapy in cancer
patients